| Dermatology | Lifetime | 48 | FR 2 | 99.66 |
| Rheumatology | Lifetime | 911 | FR 34 | 94.68 |
| Immunology and Allergy | Lifetime | 373 | FR 5 | 94.18 |
| Complementary and Alternative Medicine | Lifetime | 891 | FR 9 | 87.76 |
| Sensory Systems | Lifetime | 515 | FR 16 | 86.54 |
| Pharmaceutical Science | Lifetime | 709 | FR 13 | 83.38 |
| Dermatology | 2021-2025 | 39 | FR 2 | 99.45 |
| Rheumatology | 2021-2025 | 224 | FR 11 | 93.49 |
| Medical Physiology | 2021-2025 | 578 | FR 15 | 91.15 |
| Immunology and Allergy | 2021-2025 | 119 | FR 4 | 89.45 |
| Sensory Systems | 2021-2025 | 136 | FR 5 | 65.07 |
| Pathology and Forensic Medicine | 2021-2025 | 578 | FR 17 | 58.88 |
| Cell Biology | 2021-2025 | 322 | FR 18 | 39.56 |
| Dermatology and Skin Diseases | Lifetime | 89 | FR 3 | 99.47 |
| Urticaria and Related Conditions | Lifetime | 58 | FR 3 | 99.21 |
| Allergic Rhinitis and Sensitization | Lifetime | 205 | FR 2 | 99.10 |
| Advancements in Transdermal Drug Delivery | Lifetime | 130 | FR 1 | 98.20 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 227 | FR 10 | 98.13 |
| Autoimmune Bullous Skin Diseases | Lifetime | 266 | FR 19 | 98.01 |
| Contact Dermatitis and Allergies | Lifetime | 222 | FR 4 | 97.98 |
| Olfactory and Sensory Function Studies | Lifetime | 386 | FR 11 | 97.04 |
| Medicine and Dermatology Studies History | Lifetime | 76 | FR 3 | 96.41 |
| Body Image and Dysmorphia Studies | Lifetime | 153 | FR 2 | 96.52 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | Lifetime | 533 | FR 4 | 95.77 |
| Nail Diseases and Treatments | Lifetime | 613 | FR 23 | 95.66 |
| Food Allergy and Anaphylaxis Research | Lifetime | 736 | FR 28 | 95.52 |
| Skin Protection and Aging | Lifetime | 673 | FR 26 | 94.82 |
| Acne and Rosacea Treatments and Effects | Lifetime | 307 | FR 14 | 94.11 |
| Complementary and Alternative Medicine Studies | Lifetime | 612 | FR 3 | 92.66 |
| Vascular Malformations and Hemangiomas | Lifetime | 756 | FR 50 | 90.34 |
| Ion Channels and Receptors | Lifetime | 742 | FR 31 | 91.19 |
| Dermatological and COVID-19 studies | Lifetime | 339 | FR 20 | 86.44 |
| Hereditary Neurological Disorders | Lifetime | 849 | FR 51 | 89.22 |
| Histiocytic Disorders and Treatments | Lifetime | 904 | FR 75 | 82.82 |
| Neonatal skin health care | Lifetime | 724 | FR 31 | 56.91 |
| Tattoo and Body Piercing Complications | Lifetime | 697 | FR 19 | 47.80 |
| Urticaria and Related Conditions | 2021-2025 | 21 | FR 2 | 98.73 |
| Dermatology and Skin Diseases | 2021-2025 | 72 | FR 3 | 98.90 |
| Allergic Rhinitis and Sensitization | 2021-2025 | 97 | FR 1 | 98.38 |
| Asthma and respiratory diseases | 2021-2025 | 422 | FR 9 | 96.19 |
| Medicine and Dermatology Studies History | 2021-2025 | 25 | FR 1 | 86.80 |
| Advancements in Transdermal Drug Delivery | 2021-2025 | 396 | FR 1 | 87.24 |
| Salivary Gland Disorders and Functions | 2021-2025 | 322 | FR 18 | 83.76 |
| Contact Dermatitis and Allergies | 2021-2025 | 319 | FR 16 | 84.82 |
| Body Image and Dysmorphia Studies | 2021-2025 | 218 | FR 4 | 81.56 |
| Olfactory and Sensory Function Studies | 2021-2025 | 921 | FR 36 | 76.52 |
| Complementary and Alternative Medicine Studies | 2021-2025 | 815 | FR 10 | 66.05 |
| Hidradenitis Suppurativa and Treatments | 2021-2025 | 983 | FR 27 | 43.34 |
| Neonatal skin health care | 2021-2025 | 162 | FR 4 | 41.92 |
| Skin Diseases and Diabetes | 2021-2025 | 690 | FR 38 | 39.60 |
